Peter Reinisch Ph.D Overview
Peter Reinisch Ph.D General Information
Biography
Dr. Peter Reinisch serves as a Partner at Global Life Science Ventures. He has over 14 years of experience in the life science industry that included senior management positions in the Corange group (Boehringer Mannheim and DePuy) for 11 years. He was responsible for the strategic coordination and business development of the diagnostics business worldwide. From 1994 to 1996 he advised Boehringer Mannheim and Co range, including from 1995 on the setting up of GLS I. He has acted as a board member, or attendee, with a number of portfolio companies, five of which are already public - four by IPO, one by reverse take-over. In addition, another company recently exited through a trade sale. He has been advising GLS I and GLSV II since the beginning in 1996 and is Managing Director of the advisory company based in Zug/Switzerland. Prior to Corange/Boehringer Mannheim, Dr. Reinisch held positions of increasing responsibility with Brown Boveri, the Institute for Automation, the Denner Group, and McKinsey and Co., where he concentrated on high technology industries. He became CEO of Pfister, one of his clients. Dr. Reinisch, born in 1940, first studied mechanical engineering, then graduated summa cum laude with a doctorate in Business Administration ("Betriebswissenschaften") from the Technical University of Vienna.
Contact Information
Address
- Tal 26
- 80331 Munich
- Germany
Peter Reinisch Ph.D Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Global Life Science Ventures | Investor | Partner | Munich, Germany | Venture Capital | 0000-00-00 |
Peter Reinisch Ph.D Lead Partner on Deals (6)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Nabriva Therapeutics | 07-Apr-2015 | Later Stage VC (Series B) | 00000 | Completed | Drug Discovery | Dublin, Ireland |
Nabriva Therapeutics | 01-Mar-2012 | 00000000000 00 | Completed | Drug Discovery | Dublin, Ireland | |
Nabriva Therapeutics | 01-Jul-2011 | 00000000000 00 | Completed | Drug Discovery | Dublin, Ireland | |
Nabriva Therapeutics | 01-Oct-2010 | 00000 00000 00 | 000.00 | Completed | Drug Discovery | Dublin, Ireland |
Nabriva Therapeutics | 28-Oct-2009 | Early Stage VC | 000.00 | Completed | Drug Discovery | Dublin, Ireland |
Nabriva Therapeutics | 06-Feb-2006 | Secondary Transaction - Private | 000.00 | Completed | Drug Discovery | Dublin, Ireland |
Peter Reinisch Ph.D Network (37)
Board Members (14)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Colin Broom MD | Nabriva Therapeutics | Nabriva Therapeutics | Dublin, Ireland | 0000-00-00 |
George Talbot MD | Nabriva Therapeutics | Self | Dublin, Ireland | 0000-00-00 |
0000 0ö000 | Nabriva Therapeutics | Novartis Venture Fund | Dublin, Ireland | 0000-00-00 |
0000 000000 | Nabriva Therapeutics | Self | Dublin, Ireland | 0000-00-00 |
0000 000000 | Nabriva Therapeutics | OrbiMed | Dublin, Ireland | 0000-00-00 |
Portfolio Executives (21)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Christine Guico-Pabia | Nabriva Therapeutics | Chief Medical Officer | 07-Apr-2015 | Dublin, Ireland |
Daniel Dolan | Nabriva Therapeutics | Chief Financial Officer, Finance & Chief Accounting Officer, Accounting | 07-Apr-2015 | Dublin, Ireland |
00000000 | Nabriva Therapeutics | Freelancer Pharmacology & BD | 07-Apr-2015 | Dublin, Ireland |
0000 0000 | Nabriva Therapeutics | Head, Business Development | 07-Apr-2015 | Dublin, Ireland |
0. 000000 | Nabriva Therapeutics | Chief Executive Officer & General Counsel, Legal | 07-Apr-2015 | Dublin, Ireland |
Fund Team Members (2)
Name | Investor | Fund | Fund Location |
---|---|---|---|
0000 0ü0000 | Global Life Science Ventures | 000000 0000 | Munich, Germany |
Peter Reinisch Ph.D Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Global Life Science Ventures Fund II | Global Life Science Ventures | Venture - General | Liquidated | 2002 | 00000 | 000000 | 000000 |
Peter Reinisch Ph.D FAQs
-
Who is Peter Reinisch Ph.D?
Dr. Peter Reinisch serves as a Partner at Global Life Science Ventures.
-
How much does Peter Reinisch Ph.D typically invest?
Peter Reinisch Ph.D's median deal size is 000000.
-
What is Peter Reinisch Ph.D’s main position?
Peter Reinisch Ph.D’s primary position is Partner.
-
What are the contact details for Peter Reinisch Ph.D?
Peter Reinisch Ph.D’s email address is p.Loremipsum@dolors and his phone number is +49 089 0000000.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »